Welcome to our dedicated page for APNW news (Ticker: APNW), a resource for investors and traders seeking the latest updates and insights on APNW stock.
Apeiron Capital Investment Corp. (APNW) is a special purpose acquisition company navigating liquidation proceedings following the termination of its proposed business combination. This page serves as the definitive source for verified news and official communications regarding shareholder redemptions, regulatory filings, and corporate actions.
Investors and stakeholders will find timely updates on the distribution of trust account funds, warrant status, and dissolution procedures. All content is curated to provide transparent insights into the company's adherence to SEC guidelines and equitable treatment of public shareholders.
The repository includes essential documents such as press releases detailing redemption timelines, filings with regulatory authorities, and management communications regarding liquidation milestones. Regular updates ensure stakeholders maintain awareness of critical developments affecting their holdings.
Bookmark this page for direct access to APNW's evolving news landscape. For comprehensive understanding of the liquidation process and its implications, we recommend checking back frequently as new information becomes available through official channels.
GIO World Health Ltd has announced a business combination agreement with Apeiron Capital Investment Corp (APNC) to take GIO public, valuing the company at a pre-money enterprise value of $250 million. Post-closing, current GIO shareholders will maintain 100% equity and approximately 80.83% ownership in the combined entity, which will be named GIO World Health Holdings, Inc. The transaction aims to provide a platform for GIO's stem cell treatments and other products. The deal is anticipated to close in the second half of 2023, pending shareholder approvals and customary conditions.
Apeiron Capital Investment Corp. (NYSE: APN U) announced on December 29, 2021, that starting December 30, holders of its IPO units can separately trade shares of Class A common stock (symbol: APN) and warrants (symbol: APN W). No fractional warrants will be issued upon separation, and the units that remain unseparated will continue trading under the symbol APN U. The Company is a blank check firm aiming for mergers or acquisitions, primarily in the financial technology, media, gaming, and wealth-advisory sectors.
Apeiron Capital Investment Corp. closed its IPO of 17,250,000 units at $10.00 each, including the full exercise of the underwriters' over-allotment option. The units began trading on the NYSE under the ticker symbol 'APNU' on November 9, 2021. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with each whole warrant exercisable at $11.50 per share. The Company aims for business combinations mainly in financial technology, media, gaming, and wealth-advisory sectors.
Apeiron Capital Investment Corp. announced the pricing of its initial public offering (IPO) of 15,000,000 units at $10.00 per unit, set to begin trading on the NYSE under the ticker APN U on November 9, 2021. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with whole warrants exercisable at $11.50 per share. The offering is expected to close on November 12, 2021, pending customary conditions. The company intends to focus on mergers in the FTMG sectors, while Cantor Fitzgerald serves as the offering manager.
